Company intelligence / Profile preview

Zymtronix

Ithaca, New York, United States

Ownership: Private
Employees: ~22
Development stage: Other

Overview

Zymtronix is a pre-commercial biotechnology company pioneering sustainable biomanufacturing using cell-free, multi-enzyme platforms for continuous production of high-value molecules in agriculture, nutrition, and potential health applications. They recently demonstrated scalable production of DSLNT (a human milk oligosaccharide) and field testing of bioenhanced crop protection products.[2][5]

Therapeutic areas: Gastroenterology
Modalities: EnzymeBiologicSmall molecule
Industry: Non-Drug Biotech

Partnerships

Tate & Lyle

Beyond the preview

Go deeper on Zymtronix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zymtronix.

Explore the full profile